Immunomedics is a leader in next generation antibody-drug conjugate (ADC) technology, committed to helping transform the lives of people with hard-to-treat cancers. Our proprietary ADC binds to Trop-2-expressing cancer cells and is internalized with the subsequent release of SN-38 via hydrolysis of the linker. SN-38 interacts with topoisomerase I and prevents re-ligation of topoisomerase I-induced…
Karyopharm Therapeutics is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets in cancer and other major diseases. Karyopharm’s Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. The company was founded in…
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its…
MorphoSys is a clinical stage biopharmaceutical company headquartered in Munich, Germany. MorphoSys is dedicated to the discovery, development and commercialization of exceptional, innovative therapies for patients suffering from serious diseases. The focus is on cancer. Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed…
About Natera Natera is a global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on oncology, reproductive health, and organ transplantation. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. Natera’s…
Coherus is led by a team of biotech industry pioneers focused on disrupting the status-quo and driving tangible change in healthcare. Many of our leaders were directly involved in developing, manufacturing, and commercializing blockbuster biologics that elevated biologics from niche to mainstream medicine. Today, the team is unlocking the true potential of this category and…
Puma Biotechnology focus is on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
EMD Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany – a leading science and technology company – in the U.S. and Canada, focused exclusively on specialty care. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in…
Exelixis, Inc., from the Greek word for “evolution,” is a biopharmaceutical company committed to developing and commercializing small molecule therapies with the potential to improve the treatment of cancer.
Every day, too many people miss out on the beauty and richness of life: A morning cup of coffee, reading to a grandchild, noticing a neighbor’s garden while out for a walk. These are treasures when someone has the strength, vitality, and opportunity to enjoy them. However, to a person dealing with life-threatening illness, opportunities…
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. They apply their expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of their business strategy. The Novartis portfolio focuses on three leading divisions – Pharmaceuticals, Alcon and Sandoz – that…
SANDOZ, a division of Novartis, is one of the largest manufacturers of generic pharmaceuticals and biosimilars in the United States. Sandoz has been at the forefront of biotechnology development and innovation for the past 70 years, developing, manufacturing, and distributing competitive, high-quality pharmaceuticals. By actively investing in the future of biosimilars, Sandoz continues to deliver on…
Eisai’s Commitment to Oncology Eisai’s hhc (human health care) mission is to give first thoughts to patients and their families by developing drugs for diseases with significant unmet medical need. Nowhere is this more compelling than in oncology, one of Eisai’s long-standing therapeutic areas of focus since 1987. Eisai continues to grow its commitment to…
Taiho Oncology, Inc., a division of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd., has built a world class clinical development organization that works urgently to develop innovative cancer treatments. Taiho has an oral oncology pipeline consisting of both novel antimetabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the…
The importance of ONE package. As part of AmerisourceBergen, Oncology Supply meticulously distributes chemotherapy, immunotherapy and supportive care products to community oncology practices nationwide from our office and distribution center in Dothan, Alabama. As your trusted supplier and solutions partner, we go beyond the product, delivering the key knowledge that creates opportunities for growth, solutions…
Company Overview Patient Assistance Programs Overview People are at the heart of what drives Teva Oncology. As a top 10 oncology company in the US, we strive to improve the lives of people affected by cancer. Our focus is to provide solutions in hematologic malignancies, solid tumors and supportive care. At Teva Oncology, our vision…
For more than 30 years, Janssen Biotech, Inc. has delivered on the promise of new treatments and ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative firsts, Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, urology and nephrology. With the same unwavering…
© 2020 FLASCO | Premium Website Design by The HDG
